2016
DOI: 10.1016/j.actatropica.2016.08.026
|View full text |Cite
|
Sign up to set email alerts
|

Effects of linalool and eugenol on the survival of Leishmania ( L .) infantum chagasi within macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
20
0
3

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 44 publications
1
20
0
3
Order By: Relevance
“…Dutra et al have already examined leishmanicidal effect of linalool on L. infantum chagasi . However when axenic amastigotes were treated with linalool, IC 50 was 550 µg/mL [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Dutra et al have already examined leishmanicidal effect of linalool on L. infantum chagasi . However when axenic amastigotes were treated with linalool, IC 50 was 550 µg/mL [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…As mentioned previously, eugenol was characterized as the major compound (86.5%) of the most interesting EO extracted from our Vietnamese sample of O. gratissimum . Literature data indicated a moderate effect on L. amazonensis and a less interesting activity against L. infantum chagasi of eugenol [ 23 , 24 , 25 ]. On L. donovani , along with a moderate in vitro activity, in vivo effect of eugenol (emulsified) was determined.…”
Section: Discussionmentioning
confidence: 99%
“…Linalool also contains both enantiomers in plant extract [6,8]. The biological activities of linalool have been reported in racemate and each isomer, e.g., antileishmanial activity in rac-linalool [9], anesthetic activity in (S)-(+)-linalool [10], and acaricidal activity in (R)-(−)-linalool [11]. These enantiomers have different fragrance property [6,8] and biological activity between (R)-(−)-linalool and (S)-(+)-linalool [12].…”
Section: Introductionmentioning
confidence: 99%
“…A range of therapies exists for the treatment of inflammation-driven diseases, which can be summarized as non-steroidal anti-inflammatory drugs (NSAIDs), corticoids and steroidal-related drugs (Ward et al, 2008). Despite of these notable successes, there are still major unmet medical needs in the treatment of inflammatory diseases and the development of new anti-inflammatory drugs features, prominently in the research portfolios of most pharmaceutical and biotech companies (Dutra et al, 2016;Ward et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…Natural products (NPs) continue to be an invaluable source of new chemical entities for the treatment of several diseases, including inflammatory disorders, which are still challenges in the modern medicine, with currently available drugs often not being effective (Dutra et al, 2016;Kondamudi et al, 2013;Li and Vederas, 2009;Suroowan and Mahomoodally, 2018). Flavour and fragrance components common to human diets that have been designated Generally Recognized as Safe (GRAS) by the US Food and Drug Administration (FDA), including terpenes (Juergens, 2014).…”
Section: Introductionmentioning
confidence: 99%